A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
Clinical trial NCT07430306 · RECRUITING
Trial details
- NCT number
- NCT07430306
- Sponsor
- AstraZeneca
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-13
- Primary completion
- 2029-01-26
- Enrollment
- 245
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.